Global Astigmatism Treatment Market

Astigmatism Treatment Comprehensive Study by Type (Eyeglasses, Contact lens, Orthokeratology, Laser surgeries, LASIK(Laser- Assisted In situ Keratomileusis), LASEK(Laser- Assisted Subepithelial Keratectomy), Photorefractive keratectomy), End User (Eye Hospitals, Eye care clinics, Research centers, Specialty clinics), Astigmatism (Myopic Astigmatism, Hyperopic Astigmatism, Others) Players and Region - Global Market Outlook to 2030

Astigmatism Treatment Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Astigmatism Treatment Market Overview:
An astigmatism is a form of vision problem caused by a misalignment of the cornea's shape. The lens of the eye or the cornea on the front side of the eye has an irregular curve in this disease. This induces changes in the way light passes through the retina or refraction. Astigmatism's prevalence varies with age, but it's particularly common in the first few months of life, which fuels the market's growth.

AttributesDetails
Study Period2018-2030
Base Year2023
Forecast Period2024-2030
Historical Period2018-2023
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Influencing Trend:
High Adoption of Laser Treatments for Astigmatism Treatment

Market Growth Drivers:
Rising Prevalence of Eye Disease and Increasing Innovation in the Field of Eye Care Treatment

Challenges:
Lack of Awareness among the User

Restraints:
Strict Regulations regarding the Treatment

Opportunities:
Growing Global Eye Health Policies in Developing Countries and Increase in New Innovative Varieties of Eyeglass Lenses

Competitive Landscape:
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Novartis AG (Switzerland), SeaVision USA (United States), Johnson & Johnson Services, Inc. (United States), Bausch & Lomb Incorporated (United States), CooperVision (United States) and Orion Vision Group (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Astigmatism Treatment market by 2030. Considering Market by End User, the sub-segment i.e. Eye Hospitals will boost the Astigmatism Treatment market. Considering Market by Astigmatism, the sub-segment i.e. Myopic Astigmatism will boost the Astigmatism Treatment market.

Latest Market Insights:
On November 17, 2023, Johnson & Johnson Vision announced a definitive agreement to acquire Abbott Laboratories' Abbott Medical Optics business, which includes their line of astigmatism-correcting contact lenses. The deal is expected to close in mid-2024.

In Feb 2021, To perform patient-specific eye surgery planning, dramatically improve vision and treat astigmatism, Optimo Medical AG and Ansys are incorporating high-fidelity structural simulations with cutting-edge digital twin technology into next-generation surgery preparation. Delivering a solution that powers surgical precision to maximize patient outcomes, the collaboration also drives in silico clinical trials of new eye products — significantly reducing development time and cost.

What Can be Explored with the Astigmatism Treatment Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Astigmatism Treatment Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Astigmatism Treatment
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Astigmatism Treatment market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Astigmatism Treatment market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Astigmatism Treatment Provider, Government Regulatory and Research Organizations and End-Use Industry.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Eyeglasses
  • Contact lens
  • Orthokeratology
  • Laser surgeries
  • LASIK(Laser- Assisted In situ Keratomileusis)
  • LASEK(Laser- Assisted Subepithelial Keratectomy)
  • Photorefractive keratectomy
By End User
  • Eye Hospitals
  • Eye care clinics
  • Research centers
  • Specialty clinics

By Astigmatism
  • Myopic Astigmatism
  • Hyperopic Astigmatism
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Eye Disease
      • 3.2.2. Increasing Innovation in the Field of Eye Care Treatment
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness among the User
    • 3.4. Market Trends
      • 3.4.1. High Adoption of Laser Treatments for Astigmatism Treatment
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Astigmatism Treatment, by Type, End User, Astigmatism and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Astigmatism Treatment (Value)
      • 5.2.1. Global Astigmatism Treatment by: Type (Value)
        • 5.2.1.1. Eyeglasses
        • 5.2.1.2. Contact lens
        • 5.2.1.3. Orthokeratology
        • 5.2.1.4. Laser surgeries
        • 5.2.1.5. LASIK(Laser- Assisted In situ Keratomileusis)
        • 5.2.1.6. LASEK(Laser- Assisted Subepithelial Keratectomy)
        • 5.2.1.7. Photorefractive keratectomy
      • 5.2.2. Global Astigmatism Treatment by: End User (Value)
        • 5.2.2.1. Eye Hospitals
        • 5.2.2.2. Eye care clinics
        • 5.2.2.3. Research centers
        • 5.2.2.4. Specialty clinics
      • 5.2.3. Global Astigmatism Treatment by: Astigmatism (Value)
        • 5.2.3.1. Myopic Astigmatism
        • 5.2.3.2. Hyperopic Astigmatism
        • 5.2.3.3. Others
      • 5.2.4. Global Astigmatism Treatment Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Astigmatism Treatment (Price)
      • 5.3.1. Global Astigmatism Treatment by: Type (Price)
  • 6. Astigmatism Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Novartis AG (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. SeaVision USA (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Johnson & Johnson Services, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Bausch & Lomb Incorporated (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. CooperVision (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Orion Vision Group (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
  • 7. Global Astigmatism Treatment Sale, by Type, End User, Astigmatism and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Astigmatism Treatment (Value)
      • 7.2.1. Global Astigmatism Treatment by: Type (Value)
        • 7.2.1.1. Eyeglasses
        • 7.2.1.2. Contact lens
        • 7.2.1.3. Orthokeratology
        • 7.2.1.4. Laser surgeries
        • 7.2.1.5. LASIK(Laser- Assisted In situ Keratomileusis)
        • 7.2.1.6. LASEK(Laser- Assisted Subepithelial Keratectomy)
        • 7.2.1.7. Photorefractive keratectomy
      • 7.2.2. Global Astigmatism Treatment by: End User (Value)
        • 7.2.2.1. Eye Hospitals
        • 7.2.2.2. Eye care clinics
        • 7.2.2.3. Research centers
        • 7.2.2.4. Specialty clinics
      • 7.2.3. Global Astigmatism Treatment by: Astigmatism (Value)
        • 7.2.3.1. Myopic Astigmatism
        • 7.2.3.2. Hyperopic Astigmatism
        • 7.2.3.3. Others
      • 7.2.4. Global Astigmatism Treatment Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Astigmatism Treatment (Price)
      • 7.3.1. Global Astigmatism Treatment by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Astigmatism Treatment: by Type(USD Million)
  • Table 2. Astigmatism Treatment Eyeglasses , by Region USD Million (2018-2023)
  • Table 3. Astigmatism Treatment Contact lens , by Region USD Million (2018-2023)
  • Table 4. Astigmatism Treatment Orthokeratology , by Region USD Million (2018-2023)
  • Table 5. Astigmatism Treatment Laser surgeries , by Region USD Million (2018-2023)
  • Table 6. Astigmatism Treatment LASIK(Laser- Assisted In situ Keratomileusis) , by Region USD Million (2018-2023)
  • Table 7. Astigmatism Treatment LASEK(Laser- Assisted Subepithelial Keratectomy) , by Region USD Million (2018-2023)
  • Table 8. Astigmatism Treatment Photorefractive keratectomy , by Region USD Million (2018-2023)
  • Table 9. Astigmatism Treatment: by End User(USD Million)
  • Table 10. Astigmatism Treatment Eye Hospitals , by Region USD Million (2018-2023)
  • Table 11. Astigmatism Treatment Eye care clinics , by Region USD Million (2018-2023)
  • Table 12. Astigmatism Treatment Research centers , by Region USD Million (2018-2023)
  • Table 13. Astigmatism Treatment Specialty clinics , by Region USD Million (2018-2023)
  • Table 14. Astigmatism Treatment: by Astigmatism(USD Million)
  • Table 15. Astigmatism Treatment Myopic Astigmatism , by Region USD Million (2018-2023)
  • Table 16. Astigmatism Treatment Hyperopic Astigmatism , by Region USD Million (2018-2023)
  • Table 17. Astigmatism Treatment Others , by Region USD Million (2018-2023)
  • Table 18. South America Astigmatism Treatment, by Country USD Million (2018-2023)
  • Table 19. South America Astigmatism Treatment, by Type USD Million (2018-2023)
  • Table 20. South America Astigmatism Treatment, by End User USD Million (2018-2023)
  • Table 21. South America Astigmatism Treatment, by Astigmatism USD Million (2018-2023)
  • Table 22. Brazil Astigmatism Treatment, by Type USD Million (2018-2023)
  • Table 23. Brazil Astigmatism Treatment, by End User USD Million (2018-2023)
  • Table 24. Brazil Astigmatism Treatment, by Astigmatism USD Million (2018-2023)
  • Table 25. Argentina Astigmatism Treatment, by Type USD Million (2018-2023)
  • Table 26. Argentina Astigmatism Treatment, by End User USD Million (2018-2023)
  • Table 27. Argentina Astigmatism Treatment, by Astigmatism USD Million (2018-2023)
  • Table 28. Rest of South America Astigmatism Treatment, by Type USD Million (2018-2023)
  • Table 29. Rest of South America Astigmatism Treatment, by End User USD Million (2018-2023)
  • Table 30. Rest of South America Astigmatism Treatment, by Astigmatism USD Million (2018-2023)
  • Table 31. Asia Pacific Astigmatism Treatment, by Country USD Million (2018-2023)
  • Table 32. Asia Pacific Astigmatism Treatment, by Type USD Million (2018-2023)
  • Table 33. Asia Pacific Astigmatism Treatment, by End User USD Million (2018-2023)
  • Table 34. Asia Pacific Astigmatism Treatment, by Astigmatism USD Million (2018-2023)
  • Table 35. China Astigmatism Treatment, by Type USD Million (2018-2023)
  • Table 36. China Astigmatism Treatment, by End User USD Million (2018-2023)
  • Table 37. China Astigmatism Treatment, by Astigmatism USD Million (2018-2023)
  • Table 38. Japan Astigmatism Treatment, by Type USD Million (2018-2023)
  • Table 39. Japan Astigmatism Treatment, by End User USD Million (2018-2023)
  • Table 40. Japan Astigmatism Treatment, by Astigmatism USD Million (2018-2023)
  • Table 41. India Astigmatism Treatment, by Type USD Million (2018-2023)
  • Table 42. India Astigmatism Treatment, by End User USD Million (2018-2023)
  • Table 43. India Astigmatism Treatment, by Astigmatism USD Million (2018-2023)
  • Table 44. South Korea Astigmatism Treatment, by Type USD Million (2018-2023)
  • Table 45. South Korea Astigmatism Treatment, by End User USD Million (2018-2023)
  • Table 46. South Korea Astigmatism Treatment, by Astigmatism USD Million (2018-2023)
  • Table 47. Taiwan Astigmatism Treatment, by Type USD Million (2018-2023)
  • Table 48. Taiwan Astigmatism Treatment, by End User USD Million (2018-2023)
  • Table 49. Taiwan Astigmatism Treatment, by Astigmatism USD Million (2018-2023)
  • Table 50. Australia Astigmatism Treatment, by Type USD Million (2018-2023)
  • Table 51. Australia Astigmatism Treatment, by End User USD Million (2018-2023)
  • Table 52. Australia Astigmatism Treatment, by Astigmatism USD Million (2018-2023)
  • Table 53. Rest of Asia-Pacific Astigmatism Treatment, by Type USD Million (2018-2023)
  • Table 54. Rest of Asia-Pacific Astigmatism Treatment, by End User USD Million (2018-2023)
  • Table 55. Rest of Asia-Pacific Astigmatism Treatment, by Astigmatism USD Million (2018-2023)
  • Table 56. Europe Astigmatism Treatment, by Country USD Million (2018-2023)
  • Table 57. Europe Astigmatism Treatment, by Type USD Million (2018-2023)
  • Table 58. Europe Astigmatism Treatment, by End User USD Million (2018-2023)
  • Table 59. Europe Astigmatism Treatment, by Astigmatism USD Million (2018-2023)
  • Table 60. Germany Astigmatism Treatment, by Type USD Million (2018-2023)
  • Table 61. Germany Astigmatism Treatment, by End User USD Million (2018-2023)
  • Table 62. Germany Astigmatism Treatment, by Astigmatism USD Million (2018-2023)
  • Table 63. France Astigmatism Treatment, by Type USD Million (2018-2023)
  • Table 64. France Astigmatism Treatment, by End User USD Million (2018-2023)
  • Table 65. France Astigmatism Treatment, by Astigmatism USD Million (2018-2023)
  • Table 66. Italy Astigmatism Treatment, by Type USD Million (2018-2023)
  • Table 67. Italy Astigmatism Treatment, by End User USD Million (2018-2023)
  • Table 68. Italy Astigmatism Treatment, by Astigmatism USD Million (2018-2023)
  • Table 69. United Kingdom Astigmatism Treatment, by Type USD Million (2018-2023)
  • Table 70. United Kingdom Astigmatism Treatment, by End User USD Million (2018-2023)
  • Table 71. United Kingdom Astigmatism Treatment, by Astigmatism USD Million (2018-2023)
  • Table 72. Netherlands Astigmatism Treatment, by Type USD Million (2018-2023)
  • Table 73. Netherlands Astigmatism Treatment, by End User USD Million (2018-2023)
  • Table 74. Netherlands Astigmatism Treatment, by Astigmatism USD Million (2018-2023)
  • Table 75. Rest of Europe Astigmatism Treatment, by Type USD Million (2018-2023)
  • Table 76. Rest of Europe Astigmatism Treatment, by End User USD Million (2018-2023)
  • Table 77. Rest of Europe Astigmatism Treatment, by Astigmatism USD Million (2018-2023)
  • Table 78. MEA Astigmatism Treatment, by Country USD Million (2018-2023)
  • Table 79. MEA Astigmatism Treatment, by Type USD Million (2018-2023)
  • Table 80. MEA Astigmatism Treatment, by End User USD Million (2018-2023)
  • Table 81. MEA Astigmatism Treatment, by Astigmatism USD Million (2018-2023)
  • Table 82. Middle East Astigmatism Treatment, by Type USD Million (2018-2023)
  • Table 83. Middle East Astigmatism Treatment, by End User USD Million (2018-2023)
  • Table 84. Middle East Astigmatism Treatment, by Astigmatism USD Million (2018-2023)
  • Table 85. Africa Astigmatism Treatment, by Type USD Million (2018-2023)
  • Table 86. Africa Astigmatism Treatment, by End User USD Million (2018-2023)
  • Table 87. Africa Astigmatism Treatment, by Astigmatism USD Million (2018-2023)
  • Table 88. North America Astigmatism Treatment, by Country USD Million (2018-2023)
  • Table 89. North America Astigmatism Treatment, by Type USD Million (2018-2023)
  • Table 90. North America Astigmatism Treatment, by End User USD Million (2018-2023)
  • Table 91. North America Astigmatism Treatment, by Astigmatism USD Million (2018-2023)
  • Table 92. United States Astigmatism Treatment, by Type USD Million (2018-2023)
  • Table 93. United States Astigmatism Treatment, by End User USD Million (2018-2023)
  • Table 94. United States Astigmatism Treatment, by Astigmatism USD Million (2018-2023)
  • Table 95. Canada Astigmatism Treatment, by Type USD Million (2018-2023)
  • Table 96. Canada Astigmatism Treatment, by End User USD Million (2018-2023)
  • Table 97. Canada Astigmatism Treatment, by Astigmatism USD Million (2018-2023)
  • Table 98. Mexico Astigmatism Treatment, by Type USD Million (2018-2023)
  • Table 99. Mexico Astigmatism Treatment, by End User USD Million (2018-2023)
  • Table 100. Mexico Astigmatism Treatment, by Astigmatism USD Million (2018-2023)
  • Table 101. Astigmatism Treatment: by Type(USD/Units)
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Astigmatism Treatment: by Type(USD Million)
  • Table 109. Astigmatism Treatment Eyeglasses , by Region USD Million (2025-2030)
  • Table 110. Astigmatism Treatment Contact lens , by Region USD Million (2025-2030)
  • Table 111. Astigmatism Treatment Orthokeratology , by Region USD Million (2025-2030)
  • Table 112. Astigmatism Treatment Laser surgeries , by Region USD Million (2025-2030)
  • Table 113. Astigmatism Treatment LASIK(Laser- Assisted In situ Keratomileusis) , by Region USD Million (2025-2030)
  • Table 114. Astigmatism Treatment LASEK(Laser- Assisted Subepithelial Keratectomy) , by Region USD Million (2025-2030)
  • Table 115. Astigmatism Treatment Photorefractive keratectomy , by Region USD Million (2025-2030)
  • Table 116. Astigmatism Treatment: by End User(USD Million)
  • Table 117. Astigmatism Treatment Eye Hospitals , by Region USD Million (2025-2030)
  • Table 118. Astigmatism Treatment Eye care clinics , by Region USD Million (2025-2030)
  • Table 119. Astigmatism Treatment Research centers , by Region USD Million (2025-2030)
  • Table 120. Astigmatism Treatment Specialty clinics , by Region USD Million (2025-2030)
  • Table 121. Astigmatism Treatment: by Astigmatism(USD Million)
  • Table 122. Astigmatism Treatment Myopic Astigmatism , by Region USD Million (2025-2030)
  • Table 123. Astigmatism Treatment Hyperopic Astigmatism , by Region USD Million (2025-2030)
  • Table 124. Astigmatism Treatment Others , by Region USD Million (2025-2030)
  • Table 125. South America Astigmatism Treatment, by Country USD Million (2025-2030)
  • Table 126. South America Astigmatism Treatment, by Type USD Million (2025-2030)
  • Table 127. South America Astigmatism Treatment, by End User USD Million (2025-2030)
  • Table 128. South America Astigmatism Treatment, by Astigmatism USD Million (2025-2030)
  • Table 129. Brazil Astigmatism Treatment, by Type USD Million (2025-2030)
  • Table 130. Brazil Astigmatism Treatment, by End User USD Million (2025-2030)
  • Table 131. Brazil Astigmatism Treatment, by Astigmatism USD Million (2025-2030)
  • Table 132. Argentina Astigmatism Treatment, by Type USD Million (2025-2030)
  • Table 133. Argentina Astigmatism Treatment, by End User USD Million (2025-2030)
  • Table 134. Argentina Astigmatism Treatment, by Astigmatism USD Million (2025-2030)
  • Table 135. Rest of South America Astigmatism Treatment, by Type USD Million (2025-2030)
  • Table 136. Rest of South America Astigmatism Treatment, by End User USD Million (2025-2030)
  • Table 137. Rest of South America Astigmatism Treatment, by Astigmatism USD Million (2025-2030)
  • Table 138. Asia Pacific Astigmatism Treatment, by Country USD Million (2025-2030)
  • Table 139. Asia Pacific Astigmatism Treatment, by Type USD Million (2025-2030)
  • Table 140. Asia Pacific Astigmatism Treatment, by End User USD Million (2025-2030)
  • Table 141. Asia Pacific Astigmatism Treatment, by Astigmatism USD Million (2025-2030)
  • Table 142. China Astigmatism Treatment, by Type USD Million (2025-2030)
  • Table 143. China Astigmatism Treatment, by End User USD Million (2025-2030)
  • Table 144. China Astigmatism Treatment, by Astigmatism USD Million (2025-2030)
  • Table 145. Japan Astigmatism Treatment, by Type USD Million (2025-2030)
  • Table 146. Japan Astigmatism Treatment, by End User USD Million (2025-2030)
  • Table 147. Japan Astigmatism Treatment, by Astigmatism USD Million (2025-2030)
  • Table 148. India Astigmatism Treatment, by Type USD Million (2025-2030)
  • Table 149. India Astigmatism Treatment, by End User USD Million (2025-2030)
  • Table 150. India Astigmatism Treatment, by Astigmatism USD Million (2025-2030)
  • Table 151. South Korea Astigmatism Treatment, by Type USD Million (2025-2030)
  • Table 152. South Korea Astigmatism Treatment, by End User USD Million (2025-2030)
  • Table 153. South Korea Astigmatism Treatment, by Astigmatism USD Million (2025-2030)
  • Table 154. Taiwan Astigmatism Treatment, by Type USD Million (2025-2030)
  • Table 155. Taiwan Astigmatism Treatment, by End User USD Million (2025-2030)
  • Table 156. Taiwan Astigmatism Treatment, by Astigmatism USD Million (2025-2030)
  • Table 157. Australia Astigmatism Treatment, by Type USD Million (2025-2030)
  • Table 158. Australia Astigmatism Treatment, by End User USD Million (2025-2030)
  • Table 159. Australia Astigmatism Treatment, by Astigmatism USD Million (2025-2030)
  • Table 160. Rest of Asia-Pacific Astigmatism Treatment, by Type USD Million (2025-2030)
  • Table 161. Rest of Asia-Pacific Astigmatism Treatment, by End User USD Million (2025-2030)
  • Table 162. Rest of Asia-Pacific Astigmatism Treatment, by Astigmatism USD Million (2025-2030)
  • Table 163. Europe Astigmatism Treatment, by Country USD Million (2025-2030)
  • Table 164. Europe Astigmatism Treatment, by Type USD Million (2025-2030)
  • Table 165. Europe Astigmatism Treatment, by End User USD Million (2025-2030)
  • Table 166. Europe Astigmatism Treatment, by Astigmatism USD Million (2025-2030)
  • Table 167. Germany Astigmatism Treatment, by Type USD Million (2025-2030)
  • Table 168. Germany Astigmatism Treatment, by End User USD Million (2025-2030)
  • Table 169. Germany Astigmatism Treatment, by Astigmatism USD Million (2025-2030)
  • Table 170. France Astigmatism Treatment, by Type USD Million (2025-2030)
  • Table 171. France Astigmatism Treatment, by End User USD Million (2025-2030)
  • Table 172. France Astigmatism Treatment, by Astigmatism USD Million (2025-2030)
  • Table 173. Italy Astigmatism Treatment, by Type USD Million (2025-2030)
  • Table 174. Italy Astigmatism Treatment, by End User USD Million (2025-2030)
  • Table 175. Italy Astigmatism Treatment, by Astigmatism USD Million (2025-2030)
  • Table 176. United Kingdom Astigmatism Treatment, by Type USD Million (2025-2030)
  • Table 177. United Kingdom Astigmatism Treatment, by End User USD Million (2025-2030)
  • Table 178. United Kingdom Astigmatism Treatment, by Astigmatism USD Million (2025-2030)
  • Table 179. Netherlands Astigmatism Treatment, by Type USD Million (2025-2030)
  • Table 180. Netherlands Astigmatism Treatment, by End User USD Million (2025-2030)
  • Table 181. Netherlands Astigmatism Treatment, by Astigmatism USD Million (2025-2030)
  • Table 182. Rest of Europe Astigmatism Treatment, by Type USD Million (2025-2030)
  • Table 183. Rest of Europe Astigmatism Treatment, by End User USD Million (2025-2030)
  • Table 184. Rest of Europe Astigmatism Treatment, by Astigmatism USD Million (2025-2030)
  • Table 185. MEA Astigmatism Treatment, by Country USD Million (2025-2030)
  • Table 186. MEA Astigmatism Treatment, by Type USD Million (2025-2030)
  • Table 187. MEA Astigmatism Treatment, by End User USD Million (2025-2030)
  • Table 188. MEA Astigmatism Treatment, by Astigmatism USD Million (2025-2030)
  • Table 189. Middle East Astigmatism Treatment, by Type USD Million (2025-2030)
  • Table 190. Middle East Astigmatism Treatment, by End User USD Million (2025-2030)
  • Table 191. Middle East Astigmatism Treatment, by Astigmatism USD Million (2025-2030)
  • Table 192. Africa Astigmatism Treatment, by Type USD Million (2025-2030)
  • Table 193. Africa Astigmatism Treatment, by End User USD Million (2025-2030)
  • Table 194. Africa Astigmatism Treatment, by Astigmatism USD Million (2025-2030)
  • Table 195. North America Astigmatism Treatment, by Country USD Million (2025-2030)
  • Table 196. North America Astigmatism Treatment, by Type USD Million (2025-2030)
  • Table 197. North America Astigmatism Treatment, by End User USD Million (2025-2030)
  • Table 198. North America Astigmatism Treatment, by Astigmatism USD Million (2025-2030)
  • Table 199. United States Astigmatism Treatment, by Type USD Million (2025-2030)
  • Table 200. United States Astigmatism Treatment, by End User USD Million (2025-2030)
  • Table 201. United States Astigmatism Treatment, by Astigmatism USD Million (2025-2030)
  • Table 202. Canada Astigmatism Treatment, by Type USD Million (2025-2030)
  • Table 203. Canada Astigmatism Treatment, by End User USD Million (2025-2030)
  • Table 204. Canada Astigmatism Treatment, by Astigmatism USD Million (2025-2030)
  • Table 205. Mexico Astigmatism Treatment, by Type USD Million (2025-2030)
  • Table 206. Mexico Astigmatism Treatment, by End User USD Million (2025-2030)
  • Table 207. Mexico Astigmatism Treatment, by Astigmatism USD Million (2025-2030)
  • Table 208. Astigmatism Treatment: by Type(USD/Units)
  • Table 209. Research Programs/Design for This Report
  • Table 210. Key Data Information from Secondary Sources
  • Table 211. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Astigmatism Treatment: by Type USD Million (2018-2023)
  • Figure 5. Global Astigmatism Treatment: by End User USD Million (2018-2023)
  • Figure 6. Global Astigmatism Treatment: by Astigmatism USD Million (2018-2023)
  • Figure 7. South America Astigmatism Treatment Share (%), by Country
  • Figure 8. Asia Pacific Astigmatism Treatment Share (%), by Country
  • Figure 9. Europe Astigmatism Treatment Share (%), by Country
  • Figure 10. MEA Astigmatism Treatment Share (%), by Country
  • Figure 11. North America Astigmatism Treatment Share (%), by Country
  • Figure 12. Global Astigmatism Treatment: by Type USD/Units (2018-2023)
  • Figure 13. Global Astigmatism Treatment share by Players 2023 (%)
  • Figure 14. Global Astigmatism Treatment share by Players (Top 3) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 17. Novartis AG (Switzerland) Revenue: by Geography 2023
  • Figure 18. SeaVision USA (United States) Revenue, Net Income and Gross profit
  • Figure 19. SeaVision USA (United States) Revenue: by Geography 2023
  • Figure 20. Johnson & Johnson Services, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Johnson & Johnson Services, Inc. (United States) Revenue: by Geography 2023
  • Figure 22. Bausch & Lomb Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 23. Bausch & Lomb Incorporated (United States) Revenue: by Geography 2023
  • Figure 24. CooperVision (United States) Revenue, Net Income and Gross profit
  • Figure 25. CooperVision (United States) Revenue: by Geography 2023
  • Figure 26. Orion Vision Group (United States) Revenue, Net Income and Gross profit
  • Figure 27. Orion Vision Group (United States) Revenue: by Geography 2023
  • Figure 28. Global Astigmatism Treatment: by Type USD Million (2025-2030)
  • Figure 29. Global Astigmatism Treatment: by End User USD Million (2025-2030)
  • Figure 30. Global Astigmatism Treatment: by Astigmatism USD Million (2025-2030)
  • Figure 31. South America Astigmatism Treatment Share (%), by Country
  • Figure 32. Asia Pacific Astigmatism Treatment Share (%), by Country
  • Figure 33. Europe Astigmatism Treatment Share (%), by Country
  • Figure 34. MEA Astigmatism Treatment Share (%), by Country
  • Figure 35. North America Astigmatism Treatment Share (%), by Country
  • Figure 36. Global Astigmatism Treatment: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Novartis AG (Switzerland)
  • SeaVision USA (United States)
  • Johnson & Johnson Services, Inc. (United States)
  • Bausch & Lomb Incorporated (United States)
  • CooperVision (United States)
  • Orion Vision Group (United States)
Select User Access Type

Key Highlights of Report


Jan 2024 230 Pages 66 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Astigmatism Treatment Market Quantitative research analysis
Global Astigmatism Treatment Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Astigmatism Treatment market are Novartis AG (Switzerland), SeaVision USA (United States), Johnson & Johnson Services, Inc. (United States), Bausch & Lomb Incorporated (United States), CooperVision (United States) and Orion Vision Group (United States), to name a few.
"High Adoption of Laser Treatments for Astigmatism Treatment" is seen as one of major influencing trends for Astigmatism Treatment Market during projected period 2023-2030.
Eyeglasses segment in Global market to hold robust market share owing to "Rising Prevalence of Eye Disease ".

Know More About Global Astigmatism Treatment Market Report?

Have a Query? Click Here

Other Related Reports

Cutaneous Squamous Cell Carcinoma Comprehensive Study by Application (Hospitals, Cancer Institutes, Ambulatory Surgical Centers, Others), Treatment (Surgical (Moh’s Micrographic Surgery (MMS) and Ele...
$ 3450
Diverticular Treatment Comprehensive Study by Type (Antibiotics Treatment, Symptomatic Treatment), Application (Diverticulosis, Diverticulitis), Indication (Symptomatic Uncomplicated Diverticular Dis...
$ 3750
Bone Infection Treatment Comprehensive Study by Type (Penicillin, Cephalosporin, Aminoglycosides, Tetracycline, Others), Route of Administration (Oral, Topical, Injectable), Distribution Channel (Hos...
$ 3450
Cell Lymphoma Treatment Comprehensive Study by Type (Oral, Injection), Types (Topical products, Systematic Products), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
$ 3500
Refractory Multiple Myeloma Treatment Comprehensive Study by Type (Immunomodulatory drugs (IMiDs) (Thalidomide (THAL), Lenalidomide, Pomalidomide, Bortezomib, Carfilzomib), Cytotoxic agents, High-Dos...
$ 3750
Hypermetropia Treatment Comprehensive Study by Type (Prescription, Surgery), End-User (Hospitals, Specialty Centres, Diagnostic Centres, Clinics, Others), Laser Procedure Types (Photorefractive Kerat...
$ 3650